European founders increasingly face pressure to relocate to Silicon Valley, with investors and peers questioning when they'll move. Yet this mass migration overlooks advantages of staying local. Tandem Health succeeded by doubling down on European markets, using fragmentation as competitive edge rather than obstacle.

European market fragmentation enables healthier competition than concentrated US sectors. Healthcare EHR markets in the US are dominated by two players controlling 70%, leaving little room for innovation. European compliance with regulations like GDPR and AI Act, while complex, creates barriers competitors won't replicate once mastered.

The 64% of European founders expanding to the US at early stages risks making Europe permanently dependent on Silicon Valley to train its talent. Building genuinely European products—locally accountable and compliant—provides commercial advantages in an era of declining trust in American Big Tech. Europe needs founders to stay to build globally competitive companies.